Literature DB >> 7682435

Inhibition of wound healing in mice by local interferon alpha/beta injection.

A J Stout1, I Gresser, W D Thompson.   

Abstract

Tumour vascular endothelium has been observed previously to be damaged by local injection of interferon alpha/beta, apparently before the onset of necrosis and regression of experimental tumours. In order to distinguish the effect of interferon alpha/beta on the vasculature from direct effects on tumour, the angiogenesis of wound healing was chosen for study. Injection of interferon alpha/beta subcutaneously adjacent to each wound at days 0 to 4 resulted in a markedly reduced rate of healing with poor edge reunion by day 3. Histologically, there was delay in the initiation of proliferation of not only capillary buds, but also fibroblasts and, to a lesser extent, epithelium across the incision. Nevertheless, no endothelial injury was seen at light or electron microscopic level. Healing subsequently resumed the normal pattern, though delayed, day 9 wounds resembling normal day 5 wounds. We conclude that interferon alpha/beta inhibits wound healing in mice by inhibition of proliferation of many cell types in addition to endothelium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682435      PMCID: PMC2002231     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  20 in total

Review 1.  Interferon treatment of human neoplasia.

Authors:  H Strander
Journal:  Adv Cancer Res       Date:  1986       Impact factor: 6.242

2.  Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses.

Authors:  Y A Sidky; E C Borden
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

3.  Letter: Inhibitory effect of potent interferon preparations on the regeneration of mouse liver after partial hepatectomy.

Authors:  C Frayssinet; I Gresser; M Tovey; P Lindahl
Journal:  Nature       Date:  1973-09-21       Impact factor: 49.962

Review 4.  The fibroblast and wound repair.

Authors:  R Ross
Journal:  Biol Rev Camb Philos Soc       Date:  1968-02

5.  Inhibition of cell motility by interferon.

Authors:  D Brouty-Boyé; B R Zetter
Journal:  Science       Date:  1980-05-02       Impact factor: 47.728

6.  Effects of alpha and beta interferons on cultured human keratinocytes.

Authors:  M Yaar; R L Karassik; L E Schnipper; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1985-07       Impact factor: 8.551

Review 7.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

8.  Electrophoretically pure mouse interferon exerts multiple biologic effects.

Authors:  I Gresser; J De Maeyer-Guignard; M G Tovey; E De Maeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  The effect of systemic human interferon-alpha administration to patients with glioblastoma multiforme.

Authors:  J Boëthius; H Blomgren; V P Collins; T Greitz; H Strander
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

10.  Inhibition of endothelial cell proliferation by gamma-interferon.

Authors:  R Friesel; A Komoriya; T Maciag
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

View more
  13 in total

1.  Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.

Authors:  R Abramovitch; H Dafni; M Neeman; A Nagler; M Pines
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.

Authors:  William M Mahoney; Jo Nadine Fleming; Stephen M Schwartz
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Effect of the prostacyclin derivate iloprost in experimental caustic esophageal burn.

Authors:  G Ekingen; M Ozden; S Sözübir; H Maral; B Müezzinoğlu; H Kahraman; B H Güvenç
Journal:  Pediatr Surg Int       Date:  2005-04-28       Impact factor: 1.827

4.  Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.

Authors:  Robert M Clancy; Androo J Markham; Tanisha Jackson; Sara E Rasmussen; Miroslav Blumenberg; Jill P Buyon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

Review 5.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

6.  Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; S B Morris; M D Burdick; M C Glass; D T Taub; M D Iannettoni; R I Whyte; R M Strieter
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

7.  Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns.

Authors:  Kemal Varim Numanoğlu; Duygu Tatli; Sibel Bektaş; Ebubekir Er
Journal:  Exp Ther Med       Date:  2014-07-17       Impact factor: 2.447

8.  The effects of 5-fluorouracil and interferon-alpha on early healing of experimental intestinal anastomoses.

Authors:  J W de Waard; T Wobbes; B M de Man; C J van der Linden; T Hendriks
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

Review 9.  Type I interferons: key players in normal skin and select cutaneous malignancies.

Authors:  Aimen Ismail; Nabiha Yusuf
Journal:  Dermatol Res Pract       Date:  2014-01-05

10.  Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10.

Authors:  Shingo Takano; Eiichi Ishikawa; Masahide Matsuda; Tetsuya Yamamoto; Akira Matsumura
Journal:  Int J Oncol       Date:  2014-08-25       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.